4 news items
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
people (34,530 men and 31,910 women) will be diagnosed
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
people (34,530 men and 31,910 women) will be diagnosed
Candel Therapeutics Receives FDA Orphan Drug Designation For CAN-2409 For The Treatment Of Pancreatic Cancer
CADL
11 Apr 24
leading cause of cancer-related death in the United States among both men and women. Based on the National Cancer Institute, Surveillance, Epidemiology
Moving Fast: Candel's (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
CADL
28 Feb 24
in recurrent HGG, led by E. Antonio Chiocca, MD, PhD, Head of the Department of Neurosurgery at Brigham & Women's Hospital and Professor at Harvard
- Prev
- 1
- Next